Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CLY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,841
Award facts
- Contract value 100% obligated
- $19,841.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,841.13 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 2, 2026, with completion scheduled for January 5, 2026. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor vehicle extending through December 2026 that enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor and SAM.gov-registered vendor, AmerisourceBergen Drug Corp serves as a critical supplier within the Defense Logistics Agency's medical supply chain, fulfilling federal procurement requirements for military and veteran healthcare systems. The Dupixent product being delivered under this order is a specialty pharmaceutical commonly used for immunological conditions. This delivery order exemplifies the company's established capability to meet federal medical supply demands through its portfolio of competitively awarded contracts with the Defense Logistics Agency, which span diverse therapeutic categories and order values.
Quick answers
Who was awarded contract SPE2DR26F9CLY?
SPE2DR26F9CLY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F9CLY worth?
The government has obligated $19,841 on SPE2DR26F9CLY.
Is contract SPE2DR26F9CLY an order under another contract?
Yes. SPE2DR26F9CLY is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CLY competed?
The extent of competition for SPE2DR26F9CLY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award